J — Jacobs Solutions Inc.

Market sentiment is positive after Q3 FY2026 adjusted EPS grew ~14% YoY to $1.84, management raised FY2026 adjusted EPS guidance to $7.20-$7.30, backlog hit a record $29B (up 27% YoY), and management said it was aggressively buying back stock. Several analysts raised price targets, with the consensus target at $162.57 and a high of $174.

Gross revenue is inflecting upward: sequential quarterly revenue went from $3.29B (Dec-25) to $3.69B (Mar-26) to $4.08B (Jun-26), with YoY growth accelerating from roughly 12% to 35%. The Sep-2024 negative revenue figure is a divestiture/reporting artifact, not an operating collapse. Reported operating results are noisy — Mar-26 showed an operating loss of $81M and net loss of $45.9M, likely from one-off charges — but surrounding quarters are solid and adjusted EPS plus guidance indicate the underlying trend is improvement, not deterioration. Still, reported GAAP margins are thin for a pass-through-heavy E&C business.

As of 2026-08-27, the trailing P/E of 52.5x is not economically meaningful because TTM EPS of $2.82 is depressed by divestiture and one-off items. On forward earnings, J is fairly valued but not cheap: $150.62 divided by the $7.25 FY2026 guidance midpoint is roughly 20.8x. That is well below its own 5-year average P/E of 31.3x, but that average predates the current business mix. Price-to-sales of 1.25x is in line with the 5-year average of 1.28x. The stock is priced for continued execution on its record backlog rather than for GAAP profitability alone.

At $150.62, the stock is discounting not just FY2026 guidance of $7.20-$7.30 but continued double-digit growth into FY2027. If J delivers the ~19% EPS growth it guided to, the forward P/E settles into the low 20s and the price is reasonable. If backlog conversion slows or AI/data-center capex pauses, the valuation cushion is thin — under a 20x multiple, fair value would be closer to $145. Watch whether record backlog translates into operating margin expansion; so far the acceleration is mostly top-line.

As of 2026-08-27, the 14-day RSI was 67.22 — strong momentum but not yet overbought. Price was +3.32% above the 20-day SMA, +11.34% above the 50-day SMA, and +13.35% above the 200-day SMA, so the trend is clearly upward. For entry timing, chasing at $150.62 after a 13% run above the 200-day carries short-term mean-reversion risk; a pullback toward the 50-day SMA (roughly $135) would offer a better risk/reward. Momentum can continue while RSI stays below 70, but this is not a low-risk entry point.

• AI and data-center infrastructure build-out is the dominant tailwind; direct AI-related work now represents 11% of adjusted net revenue and is still expanding.
• Federal and state infrastructure spending on water, transit, and clean energy provides multi-year backlog visibility.
• Nuclear energy expansion, including the UK nuclear planning mandate, adds a long-duration growth leg.
• Interest rates and government capex cycles affect project funding and the multiple investors will pay for an E&C name.
• Engineering labor supply and construction input costs remain swing factors for margin execution on fixed-price work.

• Q4 FY2026 earnings and initial FY2027 guidance, typically late November/early December 2026, is the next major catalyst.
• Capital allocation updates: continued aggressive buybacks, potential portfolio optimization, or margin-target announcements.
• Further high-value data-center, water, and nuclear contract wins; backlog conversion at a 1.4x trailing book-to-bill already supports growth.

• Margin pressure or cost overruns on large E&C projects could compress operating margins, which are already modest at 4.6% TTM.
• AI-infrastructure demand is cyclical; a pause in speculative data-center projects would hurt both revenue and sentiment.
• Leverage has risen materially — long-term debt was $3.58B at Jun-2026 versus $1.35B at Sep-2024 — and D/E is 1.24.
• Management transition and the President's open-market sale of $2.48M in August 2026 add minor governance noise.
• Divestiture-related financial discontinuities make reported comparability less reliable than the underlying adjusted metrics.

Jacobs is a well-run engineering and consulting business with record backlog, raised guidance, and durable exposure to AI power and infrastructure spending. At ~21x forward earnings and ~19% expected EPS growth, the stock is reasonably but not cheaply priced. This is a good business at a fair price — worth owning for multi-year backlog conversion, but not a bargain; the Cautiously Bullish lean reflects the rich-vs-history valuation overlay. This is analysis, not personalized financial advice.

Applied a justified forward P/E of 22.5x to the FY2026 adjusted EPS guidance midpoint of $7.25. The 22.5x multiple is roughly 1.2x expected EPS growth and a modest premium to the current ~20.8x forward P/E, reflecting record backlog and raised guidance while staying disciplined given thin margins and elevated leverage.